BioSpace News Archive

Alkermes plc Announces Intent to Separate Oncology Business

Alkermes plc today announced approval by its Board of Directors (the Board) to explore separating its commercial-stage neuroscience business and development-stage oncology business.

November 2, 2022
·
10 min read
Business

Nevro Reports Third Quarter 2022 Financial Results, Narrows Full-Year 2022 Guidance and Raises Revenue Contribution from Painful Diabetic Neuropathy

Nevro Corp., delivering comprehensive, life-changing solutions for the treatment of chronic pain, reported its financial results for the third quarter ended September 30, 2022, narrowed its full-year 2022 guidance and raised its full-year revenue contribution from painful diabetic neuropathy.

November 2, 2022
·
18 min read
Business

ChromaDex Corporation Reports Third Quarter 2022 Financial Results

ChromaDex Corp. announced financial results for the third quarter of 2022.

November 2, 2022
·
14 min read
Business

Tandem Diabetes Care Announces Third Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance

Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company, reported its financial results for the quarter ended September 30, 2022 and updated its financial guidance for the year ending December 31, 2022.

November 2, 2022
·
14 min read
Business

Tricida Provides Strategic Update

Tricida, Inc., announced that the Board of Directors has authorized Tricida to initiate a review of strategic alternatives to maximize stakeholder value.

November 2, 2022
·
3 min read
Biotech Bay

CytomX Therapeutics to Present at Upcoming November 2022 Investor Conferences

CytomX Therapeutics, Inc., a leader in the field of conditionally activated oncology therapeutics, announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in the following investor conferences in November.

November 2, 2022
·
2 min read
Business

Nephros Announces Results for Quarter Ended September 30, 2022

Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the third quarter ended September 30, 2022.

November 2, 2022
·
11 min read
Business

NANOBIOTIX Appoints Renowned Global Experts to Comprehensive Scientific Advisory Board for Potential First-in-Class Radioenhancer NBTXR3

NANOBIOTIX announced the appointment of twelve global medical experts to a Scientific Advisory Board designed to support the Company regarding development of lead therapeutic candidate NBTXR3.

November 2, 2022
·
6 min read
Business

Conformis Reports Third Quarter 2022 Financial Results

Conformis, Inc., an orthopedic medical device company that features personalized knee and hip replacement products, announced financial results for the third quarter ended September 30, 2022.

November 2, 2022
·
10 min read
Business

MIMEDX Announces Third Quarter 2022 Operating and Financial Results

MiMedx Group, Inc., a transformational placental biologics company, announced operating and financial results for the third quarter 2022, which ended September 30, 2022.

November 2, 2022
·
18 min read